15/05/2026
๐๐ก๐ ๐๐จ๐ฆ๐ฆ๐๐ซ๐๐ข๐๐ฅ๐ข๐ฌ๐๐ญ๐ข๐จ๐ง ๐๐ฅ๐ฎ๐๐ฉ๐ซ๐ข๐ง๐ญ: ๐
๐ซ๐จ๐ฆ ๐๐ง๐ญ๐๐ฅ๐ฅ๐ข๐ ๐๐ง๐๐ ๐ญ๐จ ๐๐ฆ๐ฉ๐๐๐ญ
๐๐๐ฌ๐จ๐ฎ๐ซ๐๐ ๐๐๐ง๐ญ๐ซ๐, ๐๐๐๐๐๐ ๐๐๐ซ๐ค, ๐๐ฎ๐๐ฅ๐ ๐๐ฎ๐ฆ๐ฉ๐ฎ๐ซ.
๐๐ ๐๐๐ฒ ๐๐๐๐
Delegates from MaHTAS attended a seminar hosted by MRANTI. Among the key insights gained by MaHTAS were:
๐ก The Technology Transfer Office (TTO) accelerates commercialisation by bridging academia and industry through targeted researcher training, IP protection, and structured funding.
๐ก Moving a technology forward (Technology Readiness Level) is impossible without industry partnership. Success requires a holistic ecosystem that integrates Innovation (IRL), Commercialisation (CRL), Manufacturing (MRL), and Adoption (ARL) readiness.
๐ก Effective collaboration is bottle necked by misaligned expectations and ineffective communication at both the macro (policy/industry alignment) and micro (researcher/partner dialogue) levels.
๐ก Knowledge Exchange (KE) initiatives such as private labs in tech parks and high-frequency conversation zones are essential to seamlessly share talent, infrastructure, and ideas.
๐ก Utilizing Cost-Benefit Analysis (CBA) is vital to quantify real-world monetary value, align research with government/user needs, and select the highest-impact initiatives for market adoption.
๐ก Securing early industry commitment through a risk-sharing model with the government ensures that innovations are successfully absorbed, scaled, and commercialised.
๐ก To maximize investment and accelerate real-world impact, the ecosystem must embrace a paradigm shift that views Intellectual Property (IP) not as a mere academic KPI or researcher achievement indicator, but as a dynamic asset for strategic commercialisation.
A big thank you to MRANTI for putting together this impactful talk! It provided excellent insights that will help MaHTAS better understanding on Malaysia's healthcare industry.